International research progress of risk factors, diagnosis and management in early chronic obstructive pulmonary disease.
10.3760/cma.j.cn121430-20221205-01056
- Author:
Huiru LI
1
;
Linqiong ZHOU
1
;
Chunlei DUAN
1
;
Weihong HAN
1
;
Minghang WANG
2
;
Suyun LI
2
Author Information
1. The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan, China.
2. Department of Respiratory Medicine, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, Henan, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Pulmonary Disease, Chronic Obstructive/drug therapy*;
Prognosis;
Risk Factors
- From:
Chinese Critical Care Medicine
2023;35(12):1340-1344
- CountryChina
- Language:Chinese
-
Abstract:
Chronic obstructive pulmonary disease (COPD) has a high global morbidity and mortality and a severe disease burden, yet progress in treatment and prevention has been slow in recent decades. Early COPD has few symptoms and is severely underdiagnosed and undertreated; it is crucial to search for effective clues of early COPD and provide management interventions. By reviewing the definition, risk factors, diagnosis and management interventions, this study explores the disease evolution of early-stage COPD, which can help clinical practice to develop more effective preventive and therapeutic strategies for stopping or slowing down the natural progression of the disease, improving the long-term prognosis, and reducing the disease burden.
